Records whose title is actually about this topic. Use a country filter if the list is still too broad.
Records
Bill· SS. 1160 (116th)open
United States · United States Congress · 11 April 2019
Supporting Family Mental Health in CAPTA Act This bill revises various programs that address the prevention and treatment of child abuse. For example, the bill expands the Child Welfare Information Gateway to include best practices for referrals to resources for physical, behavioral, mental health, and developmental needs. The bill also revises child abuse research programs to include elements such as (1) effective community-based resources that support behavioral and mental health; and (2) effective methods to address geographic, racial, and cultural inequities in the child welfare system. Additionally, the bill requires specified grants programs for child abuse and neglect to (1) include training about trauma-informed practices, and (2) provide specified services that address the mental health of children and families in the child welfare system.
Bill· SS. 1199 (116th)open
United States · United States Congress · 11 April 2019
Poison Center Network Enhancement Act of 2019 This bill modifies and reauthorizes through FY2024 the national poison center network program. Specifically, the bill allows the use of other communication technologies (in addition to the national toll-free number) to access poison control centers and requires the program to include toxic exposure (in addition to poisoning) in nationwide media campaigns. Further, the bill modifies the waiver limitations for poison control center accreditation.
Bill· SS. 1173 (116th)open
United States · United States Congress · 11 April 2019
Emergency Medical Services for Children Program Reauthorization Act of 2019 This bill reauthorizes through FY2024 the Emergency Medical Services for Children grant program. The program is administered by the Health Resources and Services Administration and focuses on improving emergency health care for children who are seriously ill or injured.
Resolution· SRESS.Res. 162 (116th)passed
United States · United States Congress · 11 April 2019
This resolution expresses support for the designation of April 2019 as National Donate Life Month and for promoting awareness of organ and tissue donation.
Bill· SS. 1215 (116th)referred
United States · United States Congress · 11 April 2019
National Defense Authorization Act for Fiscal Year 2020 This bill authorizes FY2020 appropriations and sets forth policies for Department of Defense (DOD) programs and activities, including military personnel strengths and military construction. It does not provide budget authority, which is provided in subsequent appropriations legislation. The bill authorizes appropriations to DOD for Procurement, including aircraft, weapons and tracked combat vehicles, shipbuilding and conversion, missiles, and space procurement; Research, Development, Test, and Evaluation; Operation and Maintenance; Working Capital Funds; the Joint Urgent Operational Needs Fund; Chemical Agents and Munitions Destruction; Drug Interdiction and Counter-Drug Activities; the Defense Inspector General; the Defense Health Program; the Armed Forces Retirement Home; the Space Force; and Overseas Contingency Operations. The bill also authorizes the FY2020 personnel strengths for active duty and reserve forces and sets forth policies regarding military personnel; compensation and other personnel benefits; health care; acquisition policy and management; DOD organization and management; civilian personnel matters; matters relating to foreign nations; strategic programs, cyber, and intelligence matters; and the establishment of the Space Force within the Air Force. The bill authorizes appropriations and sets forth policies regarding military construction for the Army, Navy, Air Force, defense agencies, the North Atlantic Treaty Organization Security Investment Program, and Guard and Reserve Forces facilities. The bill authorizes appropriations for base realignment and closure activities.
Bill· SS. 1213 (116th)referred
United States · United States Congress · 11 April 2019
Consumer Health Insurance Protection Act of 2019 This bill makes various changes to the health insurance marketplace, including (1) providing authority for the Department of Health and Human Services, or states, to prohibit health insurers from implementing unreasonable premium increases; (2) revising certain limits on cost sharing; and (3) modifying certain consumer protections.
Bill· SS. 1209 (116th)referred
United States · United States Congress · 11 April 2019
Reforming Evergreening and Manipulation that Extends Drug Years Act or the REMEDY Act This bill addresses drug patents with respect to Food and Drug Administration (FDA) approval of a drug application. Currently, when the owner of a brand-name drug approval sues a generic drug company for patent infringement based on the generic company's application for FDA approval of a generic version of the brand-name drug, there is generally a 30-month stay on the approval of the generic version. Under this bill, the stay goes into effect only if the lawsuit alleges infringement of a patent that claims the drug compound. When the U.S. Patent and Trademark Office invalidates a patent for a drug, the FDA must update its list of relevant patents for the drug.
Bill· SS. 1202 (116th)referred
United States · United States Congress · 11 April 2019
Independence at Home Act of 2019 This bill establishes a permanent Independence at Home Medical Practice Program for Medicare beneficiaries. Under the program, a primary care practice shall be accountable for (1) providing comprehensive, coordinated, continuous, and accessible care to applicable Medicare beneficiaries at home; and (2) coordinating health care across all treatment settings. Subject to meeting specified quality performance standards, a participating practice is eligible to receive an incentive payment under the program if actual expenditures for applicable beneficiaries are less than the estimated spending target established by the Centers for Medicare & Medicaid Services (CMS). The CMS shall terminate a program agreement with a participating practice if the practice (1) for the third of three consecutive years under the program, did not achieve savings; or (2) fails to meet a minimum number of quality performance standards established by the CMS. The bill extends the existing Independence at Home Medical Practice Demonstration Program pending implementation of the permanent program. In addition, the bill removes the limit on the number of beneficiaries that may participate in the demonstration program.
Bill· SS. 1195 (116th)referred
United States · United States Congress · 11 April 2019
Blue Water Navy Vietnam Veterans Act of 2019 This bill extends the presumption of service-connection for certain diseases associated with herbicide (e.g., Agent Orange) exposure to veterans who served (1) offshore of Vietnam between January 9, 1962, and May 7, 1975, or (2) in or near the Korean Demilitarized Zone between September 1, 1967, and August 31, 1971. Under a presumption of service-connection, specific disabilities or diseases diagnosed in certain veterans are presumed to have been caused by the circumstances of their military service. Health care benefits and disability compensation may then be awarded. The bill extends eligibility for health care, vocational training and rehabilitation, and monetary allowance to children with spina bifida who have at least one veteran parent who may have been exposed to an herbicide agent while serving in Thailand between January 9, 1962, and May 7, 1975. The Department of Veterans Affairs must report on the Follow-up Study of a National Cohort of Gulf War and Gulf War Era Veterans.
Bill· SS. 1191 (116th)referred
United States · United States Congress · 11 April 2019
Training the Next Generation of Primary Care Doctors Act of 2019 This bill alters funding provisions, and establishes additional reporting requirements, relating to the Teaching Health Center Graduate Medical Education Program, which is administered by the Health Resources and Services Administration (HRSA). The program supports training for primary-care-physician and dental residents at community-based clinics. The bill (1) establishes certain parameters for payments to approved and newly approved graduate medical-residency training programs, and (2) requires HRSA to publish a report regarding new and expanded programs.
Bill· SS. 1190 (116th)referred
United States · United States Congress · 11 April 2019
Rural Access to Hospice Act of 2019 This bill allows federally qualified health centers (FQHCs) and rural health centers (RHCs) to receive payment under Medicare for hospice services. Currently, attending physicians who work for FQHCs and RHCs may provide hospice services only outside of FQHC or RHC work hours and must bill Medicare under their own provider numbers; FQHCs and RHCs may not receive payment under Medicare for such services.
Bill· SS. 1170 (116th)referred
United States · United States Congress · 11 April 2019
Association Health Plans Act of 2019 This bill provides statutory authority for certain short-term, limited-duration health insurance plans and association health plans. The bill permits short-term, limited-duration plans to provide coverage for a period of less than 12 months, not including extensions. Under current law, such plans are exempt from certain market requirements of the Patient Protection and Affordable Care Act, such as coverage of individuals with preexisting conditions. The bill further permits groups or associations of employers to sponsor fully insured group health plans as if they were employers. Such plans may not discriminate based on the health factors of any prospective plan participant for the purpose of granting an employer's membership in the association or determining a participant's eligibility for benefits or premium amounts.
Bill· SS. 1169 (116th)referred
United States · United States Congress · 11 April 2019
Ensuring Timely Access to Generics Act of 2019 This bill requires the Food and Drug Administration (FDA) to consider certain factors in determining whether a petition is submitted for the primary purpose of delaying the approval of a drug application. The FDA must (1) publish a list of petitions that were submitted with an intent to delay, and (2) establish procedures to refer such petitions to the Federal Trade Commission. The FDA may establish a timeline for submitting petitions.
Bill· SS. 1140 (116th)referred
United States · United States Congress · 11 April 2019
Protecting Access to Biosimilars Act of 2019 This bill excludes biological products that were initially licensed under the Federal Food, Drug, and Cosmetic Act (FD&C Act) (e.g., insulin) from the exclusivity protections that delay the licensure of biosimilar products under the Public Health Service Act (PHS Act). (The Biologics Price Competition and Innovation Act of 2009 generally requires that biological products approved under the FD&C Act are treated as though they were approved under the PHS Act through March 23, 2020.)
Resolution· SRESS.Res. 165 (116th)passed
United States · United States Congress · 11 April 2019
This resolution affirms that vaccines and immunizations save lives and commends those who have worked to bolster global and domestic health through vaccination.
Resolution· SRESS.Res. 159 (116th)referred
United States · United States Congress · 11 April 2019
This resolution designates April 24, 2019, as Meningitis B Awareness Day. (Meningococcal disease is more commonly referred to as bacterial meningitis and can cause an infection of the lining of the brain and spinal cord.)
Bill· HRH.R. 2281 (116th)referred
United States · United States Congress · 10 April 2019
Easy Medication Access and Treatment for Opioid Addiction Act or the Easy MAT for Opioid Addiction Act This bill requires the Drug Enforcement Administration to revise regulations to allow a practitioner to administer up to a three-day supply of narcotic drugs to an individual at one time for purposes of relieving acute withdrawal symptoms while the individual awaits arrangements for narcotic treatment. Current regulations authorize up to a one-day supply of narcotic drugs for an individual at one time, for a total of up to three days.
Bill· HRH.R. 2271 (116th)referred
United States · United States Congress · 10 April 2019
Scarlett’s Sunshine on Sudden Unexpected Death Act This bill establishes various programs for the Centers for Disease Prevention and Control (CDC) to award grants to states, local agencies, and nonprofit organizations to address sudden unexpected infant and childhood deaths. The CDC must award grants to eligible applicants to (1) conduct comprehensive death scene investigations, (2) increase the rate of standardized autopsies, and (3) obtain informed consent from families to collect genetic or tissue samples for research into the causes of such deaths. The bill also provides grants for training medical examiners, and other appropriate personnel, about standardized investigative practices, including the infant or child's medical history, other circumstances surrounding the death. The Administration for Children and Families (ACF) of the Department of Health and Human Services also must provide grants to states to develop the capacity for local governments to comprehensively review 100% of all infant and child deaths and maintain the National Fatality Review Case Reporting System. Further, the CDC must use such national reporting system to compile and make publicly available summary data about sudden unexpected infant and childhood deaths. The CDC also must revise its death investigation forms to align with the form used under the national reporting system. Additionally, the bill requires the ACF to award grants to (1) promote evidence-based best practices, (2) support prevention efforts, (3) provide safe-sleep products, and (4) support the provision of services to families who have had an infant or child die from a sudden unexpected death.
Bill· HRH.R. 2283 (116th)referred
United States · United States Congress · 10 April 2019
Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2019 or the CHANGE Act of 2019 This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports. Additionally, the Centers for Medicare and Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices. The Government Accountability Office also must conduct a study of policies that may accelerate progress in Alzheimer's disease research and enhance the quality of care for individuals diagnosed with Alzheimer's disease.
Bill· HRH.R. 2282 (116th)referred
United States · United States Congress · 10 April 2019
Medicare Care Coordination Improvement Act of 2019 This bill exempts certain alternative payment models under Medicare from the general prohibition on physician self-referrals (i.e., the Stark law).
Bill· HRH.R. 2279 (116th)referred
United States · United States Congress · 10 April 2019
Safe Step Act This bill requires a group health plan to establish an exception to medication step-therapy protocol in specified cases. A medication step-therapy protocol establishes a specific sequence in which prescription drugs are covered by a group health plan or a health insurance issuer. A request for such an exception to the protocol must be granted if (1) the treatment is expected to be ineffective, (2) the treatment will cause or is likely to cause an adverse reaction to the individual, (3) the treatment is expected to decrease the individual's ability either to perform daily activities or occupational responsibilities or adhere to the treatment plan, (4) the individual is stable based on the prescription drugs already selected, or (5) there are other medical reasons that warrant withholding the treatment. The bill requires a group health plan to implement and make readily available a clear process for an individual to request an exception to the protocol. Requests must be granted no later than three days after receipt of the request. In certain cases where the life, health, and ability of the individual are jeopardized by the protocol, the request shall be granted no later than 24 hours after receipt of the request.
Law· SS. 1130 (116th)enacted
United States · United States Congress · 10 April 2019
Scarlett’s Sunshine on Sudden Unexpected Death Act This bill establishes grants to states, local agencies, and nonprofit organizations to address sudden unexpected infant and childhood deaths. The Centers for Disease Control and Prevention (CDC) must award grants to eligible applicants to (1) conduct comprehensive death scene investigations, (2) increase the rate of standardized autopsies, and (3) obtain informed consent from families to collect genetic or tissue samples for research into the causes of such deaths. The bill also provides grants for training medical examiners, and other appropriate personnel, about standardized investigative practices, including the infant or child's medical history, and other circumstances surrounding the death. Further, the Administration for Children and Families (ACF) of the Department of Health and Human Services also must provide grants to states to develop the capacity for local governments to comprehensively review 100% of all infant and child deaths and maintain the National Fatality Review Case Reporting System. Further, the CDC must use such national reporting system to compile and make publicly available summary data about sudden unexpected infant and childhood deaths. The CDC also must revise its death investigation forms to align with the form used under the national reporting system. Additionally, the bill requires the ACF to award grants to (1) promote evidence-based best practices, (2) support prevention efforts, and (3) provide safe-sleep products.
Bill· SS. 1101 (116th)open
United States · United States Congress · 10 April 2019
Better Examiner Standards and Transparency for Veterans Act of 2019 or the BEST for Vets Act of 2019 This bill provides that only health care providers who are licensed and not barred from practice may furnish medical disability examinations under the Department of Veterans Affairs pilot program related to using contract physicians for disability examinations.
Bill· HRH.R. 2269 (116th)referred
United States · United States Congress · 10 April 2019
Get Additives Out Act of 2019 This bill requires the Government Accountability Office to study the developmental, behavioral, and physical health effects of food additives on children.
Bill· HRH.R. 2268 (116th)referred
United States · United States Congress · 10 April 2019
Menstrual Products Right To Know Act of 2019 This bill prohibits the sale of a menstrual product, such as a menstrual cup, menstrual pad, tampon, or therapeutic vaginal douche apparatus, unless its labeling includes a list of ingredients.
Bill· HRH.R. 2267 (116th)referred
United States · United States Congress · 10 April 2019
Infant Formula Protection Act of 2019 This bill prohibits the sale of an infant formula if its use-by date has passed.
Bill· HRH.R. 2262 (116th)referred
United States · United States Congress · 10 April 2019
Environmental Health Workforce Act of 2019 This bill requires the Department of Health and Human Services (HHS) to develop model standards and guidelines for credentialing environmental-health workers. Additionally, HHS must develop a plan for the environmental-health workforce that includes performance measures and identifies (1) gaps between existing programs and future environmental-health workforce needs, (2) actions needed to address any identified gaps, and (3) any additional statutory authority necessary to implement such actions. The bill also specifies that environmental-health workers are eligible for public-service loan forgiveness.
Bill· HRH.R. 2254 (116th)referred
United States · United States Congress · 10 April 2019
This bill expands requirements for lead-level testing or screening as part of well-baby care under the TRICARE program of health care for members and dependents. It prescribes testing for the level of lead in the blood at the ages of both 12 and 24 months for children who may be at elevated risk of lead exposure. Test results shall be provided to state health departments (or the Centers for Disease Control and Prevention, in the case of children residing abroad). The Government Accountability Office shall study the effectiveness of such screening, testing, and treatment for lead exposure and poisoning. The Department of Defense shall maintain records concerning the year housing for military personnel was built, and members must provide notice of when their residence was built as a condition of receiving a housing allowance.
Bill· HRH.R. 2243 (116th)referred
United States · United States Congress · 10 April 2019
Territory Health Insurance Tax Relief Act of 2019 This bill lowers the annual fee on health insurers that collect premiums from residents in U.S. territories. The annual fee for a health insurer is currently calculated based on the insurer's share of total premiums from the preceding calendar year. The bill excludes premiums paid by residents of U.S. territories from a health insurer's net premiums but still includes the premiums of such residents in the determination of total premiums from the preceding year, thereby lowering the fee for these insurers. Under current law, the fee is suspended for 2019 (i.e., there is no fee based on premiums from 2018).
Bill· HRH.R. 2241 (116th)referred
United States · United States Congress · 10 April 2019
Puerto Rico Federal Matching Requirement Equity Act of 2019 This bill excludes Puerto Rico from the specified Medicaid Federal Medical Assistance Percentage (FMAP) of 55% for U.S. territories. Under current law, a state's FMAP is generally based on the state's per capita income and may range from 50% to 83%.
Bill· HRH.R. 2235 (116th)referred
United States · United States Congress · 10 April 2019
Helping Ensure Life- and Limb-Saving Access to Podiatric Physicians Act or the HELLPP Act This bill adds podiatrists as covered physicians under the Medicaid program. Additionally, the bill revises certain documentation requirements related to Medicare coverage of therapeutic shoes for individuals with diabetes. Finally, the bill subjects payments made to a Medicaid provider or supplier to a continuing levy for federal taxes owed by the provider or supplier.
Bill· HRH.R. 2222 (116th)referred
United States · United States Congress · 10 April 2019
Women and Lung Cancer Research and Preventive Services Act of 2019 This bill requires the Department of Health and Human Services to conduct an interagency review of the status of women and lung cancer. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national cancer screening strategy and public education campaign.
Bill· HRH.R. 2216 (116th)referred
United States · United States Congress · 10 April 2019
Health for Each American Less fortunate Through Help from medical professionals In Every Rural and impoverished area Act of 2019 or the HEALTHIER Act of 2019 This bill directs the Department of Health and Human Services to award two-year grants to states that adopt laws permitting the provision of specified volunteer health care services. Such laws must require that volunteer health care services are (1) administered by a health care provider that is licensed in another state, (2) within the scope of practice of such provider, and (3) provided to a rural or impoverished area within the state receiving the grant.
Resolution· HRESH.Res. 313 (116th)referred
United States · United States Congress · 10 April 2019
This resolution expresses support for the designation of Meningitis B Awareness Day. (Meningococcal disease is more commonly referred to as bacterial meningitis and can cause an infection of the lining of the brain and spinal cord.)
Resolution· HRESH.Res. 308 (116th)referred
United States · United States Congress · 10 April 2019
This resolution expresses support for the goals and ideals of National Youth HIV & AIDS Awareness Day.
Resolution· HRESH.Res. 305 (116th)referred
United States · United States Congress · 10 April 2019
This resolution expresses support for the designation of Alcohol Responsibility Month.
Bill· SS. 1137 (116th)referred
United States · United States Congress · 10 April 2019
Environmental Health Workforce Act of 2019 This bill requires the Department of Health and Human Services (HHS) to establish guidelines for credentialing environmental health workers and to create a plan to develop the environmental health workforce. Environmental health workers investigate, assess, and control hazardous environmental agents. HHS also must, within two years, conduct a study on the environmental health workforce and natural disaster preparedness.
Bill· SS. 1129 (116th)referred
United States · United States Congress · 10 April 2019
Medicare for All Act of 2019 This bill establishes a national health insurance program that is administered by the Department of Health and Human Services (HHS). Among other requirements, the program must (1) cover all U.S. residents; (2) provide for automatic enrollment of individuals upon birth or residency in the United States; and (3) cover items and services that are medically necessary or appropriate to maintain health or to diagnose, treat, or rehabilitate a health condition, including hospital services, prescription drugs, mental health and substance abuse treatment, dental and vision services, and home- and community-based long-term care. The bill prohibits cost-sharing (e.g., deductibles, coinsurance, and copayments) and other charges for covered services, with the exception of prescription drugs. Additionally, private health insurers and employers may only offer coverage that is supplemental to, and not duplicative of, benefits provided under the program. Health insurance exchanges and specified federal health programs terminate upon program implementation. However, the program does not affect coverage provided through the Department of Veterans Affairs or the Indian Health Service. Additionally, state Medicaid programs must cover certain institutional long-term care services. The bill also establishes a series of implementing provisions relating to (1) health care provider participation; (2) HHS administration; and (3) payments and costs, including the requirement that HHS negotiate prices for prescription drugs and establish a formulary. Individuals who are age 18 or younger may enroll in the program starting one year after enactment of this bill; other individuals may buy into a transitional plan or an expanded Medicare program at this time, depending on age. The bill's program must be fully implemented four years after enactment.
Bill· SS. 1126 (116th)referred
United States · United States Congress · 10 April 2019
Concentrating on High-value Alzheimer's Needs to Get to an End (CHANGE) Act of 2019 This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports. Additionally, the Centers for Medicare and Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.
Bill· SS. 1125 (116th)referred
United States · United States Congress · 10 April 2019
Protect Act This bill adds, among other provisions, requirements to the Health Insurance Portability and Accountability Act of 1996 for private health insurance plans with respect to preexisting conditions, guaranteed enrollment, and discrimination based on health-related factors. Specifically, the bill prohibits private health insurance plans from (1) limiting or excluding benefits covering preexisting conditions; (2) denying enrollment to employers or individual applicants, subject to specified limits; (3) establishing rules for eligibility based on an individual's health status; or (4) requiring an individual to a pay higher premium than similarly situated individuals enrolled in the plan based the individual's health status. Additionally, the bill prohibits plans from collecting genetic information in connection with issuing health insurance and provides requirements for workplace wellness programs connected to health insurance.
Bill· SS. 1122 (116th)referred
United States · United States Congress · 10 April 2019
Mental Health Services for Students Act of 2019 This bill provides specific statutory authority for the Project AWARE (Advancing Wellness and Resiliency in Education) State Educational Agency Grant Program that is administered by the Substance Abuse and Mental Health Services Administration. The program supports school-based mental health services, including screening, treatment, and outreach programs.
Bill· SS. 1114 (116th)referred
United States · United States Congress · 10 April 2019
Medicare Advantage Quality Payment Relief Act of 2019 This bill requires the Centers for Medicare & Medicaid Services to disregard the application of certain percentage quality increases when calculating the maximum payment that may be made to a Medicare Advantage organization.
Bill· SS. 1107 (116th)referred
United States · United States Congress · 10 April 2019
Women and Lung Cancer Research and Preventive Services Act of 2019 This bill requires the Department of Health and Human Services to conduct an interagency review of the status of women and lung cancer. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national cancer screening strategy and public education campaign.
Resolution· SRESS.Res. 157 (116th)passed
United States · United States Congress · 10 April 2019
This resolution designates April 2019 as Parkinson's Awareness Month.
Resolution· SRESS.Res. 154 (116th)referred
United States · United States Congress · 10 April 2019
This resolution recognizes (1) the significance of April 11-17, 2019, as Black Maternal Health Week; (2) that Black Maternal Health Week is an opportunity to raise national awareness of the state of black maternal health in the United States; and (3) that black women experience high, disproportionate rates of maternal mortality and morbidity.
Bill· HRH.R. 2191 (116th)open
United States · United States Congress · 9 April 2019
Veterans Cannabis Use for Safe Healing Act This bill prohibits the Department of Veterans Affairs (VA) from denying a veteran any VA benefit due to participation in a state-approved marijuana program. For veterans participating in these approved programs, the VA must ensure its health care providers (1) discuss marijuana use with such veterans and adjust treatment plans accordingly, and (2) record such use in the veterans' medical records. Under the bill, the VA shall authorize physicians and other VA health care providers to provide recommendations to veterans who are residents of states with approved programs.
Bill· HRH.R. 2183 (116th)referred
United States · United States Congress · 9 April 2019
State Flexibility and Patient Choice Act of 2019 This bill revises the procedures for states to waive certain federal health insurance requirements and implement state-administered health insurance programs. Specifically, the bill revises the affordability requirement to allow states to provide coverage of comparable affordability to what is available through the federal health insurance exchange. Further, the reviewing agencies may consider the budgetary impact of a state waiver program on other federal programs (e.g., Medicaid) when determining whether the waiver application would increase the federal deficit. Additionally, the bill applies the budget-neutrality requirement over the term of the waiver period. States may certify that a governor has the authority to apply for a waiver under current state law, as an alternative to referencing a specific state statute. The bill also provides expedited review and approval of state applications that are substantially similar to a waiver program that already has been approved.
Bill· HRH.R. 2182 (116th)referred
United States · United States Congress · 9 April 2019
Access to Birth Control Act This bill requires pharmacies to comply with certain requirements related to providing contraceptives. For example, a pharmacy must provide a customer with a requested contraceptive without delay if it is in stock and must ensure that customers are not intimidated, threatened, or harassed with respect to their requests for contraceptives. The bill establishes civil penalties and a private cause of action for violations of the bill.
Bill· HRH.R. 2172 (116th)referred
United States · United States Congress · 9 April 2019
This bill establishes a Federal Medical Assistance Percentage of 100% with respect to a U.S. territory's use of specified federal funds to provide covered drugs to low-income individuals who are eligible for the Medicare prescription drug benefit.
Bill· HRH.R. 2155 (116th)referred
United States · United States Congress · 9 April 2019
Genetic Information Privacy Act of 2019 This bill prohibits commercial genetic testing services from disclosing consumers' personally identifiable information to third parties without the consumer's express consent. In the case of the disclosure of personally identifiable information for medical research, a genetic testing service must follow the federal rules for obtaining informed consent in the context of research involving human subjects. Further, genetic testing services must provide consumers with the option to consent to disclose a consumer's genetic information but not to disclose other personally identifiable information. A genetic testing service may not condition services on obtaining consent to disclose such information. The Federal Trade Commission (FTC) must promulgate regulations establishing how genetic testing services are required to secure such personally identifiable information against unauthorized access. The bill grants the FTC and state attorneys general powers to enforce compliance with the requirements of this bill.
PreviousPage 19 of 20Next